Aim: The aim of the present study was to investigate whether the concerns patients express to a Drug Information Line about possible adverse drug reactions (ADRs) they have experienced, are sufficiently reflected by the ADR reports submitted by pharmacists to the Netherlands Pharmacovigilance Centre Lareb with regard to the type of ADRs and the drug groups involved.Methods: ADR-related questions patients addressed to the Dutch Drugs Information Line were compared with the ADR reports pharmacists sent in to Lareb in the same period. The similarities and differences between the characteristics of the suspected ADRs and the kinds of drugs mentioned were investigated, as well as the severity of the reported ADRs. To compare the two data sets an...
Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluat...
Direct patient reporting of adverse drug reactions (ADRs) is available in many countries, as patient...
Aim To determine the contribution of patients' adverse drug reaction (ADR) reports to signals detect...
Aim: The aim of the present study was to investigate whether the concerns patients express to a Drug...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigila...
OBJECTIVE: To quantify the reasons and opinions of patients who reported adverse drug reactions (ADR...
Background: There has been discussion about the acceptance of adverse drug reactions (ADRs) reported...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
Aims To develop a systematic generic method of enabling patients to report Symptoms which they belie...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
Introduction Clinical information is needed to assess the causal relationship between a drug and an ...
Adding patients to the range of potential reporters of adverse drug reactions (ADRs) may increase sp...
OBJECTIVE: To quantify the reasons and opinions of patients who reported adverse drug reactions (ADR...
Objective: To evaluate the experience of clients in Benu Pharmacy Exchange in relation to the occurr...
Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluat...
Direct patient reporting of adverse drug reactions (ADRs) is available in many countries, as patient...
Aim To determine the contribution of patients' adverse drug reaction (ADR) reports to signals detect...
Aim: The aim of the present study was to investigate whether the concerns patients express to a Drug...
Background: Changes in the European pharmacovigilance legislation make it possible for patients of a...
Patient reporting of adverse drug reactions (ADRs) has become an important element of pharmacovigila...
OBJECTIVE: To quantify the reasons and opinions of patients who reported adverse drug reactions (ADR...
Background: There has been discussion about the acceptance of adverse drug reactions (ADRs) reported...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
Aims To develop a systematic generic method of enabling patients to report Symptoms which they belie...
OBJECTIVE: To give an overview of the views of different types of reporters (patients and healthcare...
Introduction Clinical information is needed to assess the causal relationship between a drug and an ...
Adding patients to the range of potential reporters of adverse drug reactions (ADRs) may increase sp...
OBJECTIVE: To quantify the reasons and opinions of patients who reported adverse drug reactions (ADR...
Objective: To evaluate the experience of clients in Benu Pharmacy Exchange in relation to the occurr...
Background: Patients are important stakeholders in pharmacovigilance; however, little formal evaluat...
Direct patient reporting of adverse drug reactions (ADRs) is available in many countries, as patient...
Aim To determine the contribution of patients' adverse drug reaction (ADR) reports to signals detect...